Stephen Chapman
Fortuna: 24 M $ al 31/05/2026
Fortuna: 24 M $ al 31/05/2026
En la actualidad, Stephen Chapman ocupa el cargo de Presidente, Director General y Director de Natera, Inc. En su anterior carrera, el Sr. Chapman ocupó el cargo de Director Regional en Genzyme Corp. y Director de la Universidad de California, Los Ángeles. Se licenció en la Universidad de California, Los Ángeles.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NATERA, INC. 0,08 % | 04/06/2026 | 108.743 ( 0,08 % ) | 24 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NATERA, INC. | Director Ejecutivo | 02/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2010 |
American Clinical Laboratories, Inc.
American Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical and clinical labs | Director/Miembro de la Junta | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
American Clinical Laboratories, Inc.
American Clinical Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical and clinical labs | Health Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Natera, Inc.
Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.